Haploidentical Hematopoietic Stem Cell Transplantation Followed by 'Post-Cyclophosphamide': The Future of Allogeneic Stem Cell Transplant.

Clin Hematol Int · 2020 · PMC8432344 · PMID 34595443

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

One study also demonstrated significantly worse overall mortality in the nonpermissive DPB1 mismatch group [ 42 ] while a second had a nonsignificant trend toward inferior mortality [ 43 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.